When did MEDIFAST INC (MED) report earnings last quarter?
MEDIFAST INC (MED) last reported earnings on 2/17/2026.
MEDIFAST INC (MED) Earnings History & Surprises
NYSE:MED • US58470H1014
Current stock price
10.07 USD
-0.03 (-0.3%)
At close:
10.07 USD
0 (0%)
After Hours:
MED Earnings overview
Past quarterly earnings results for MEDIFAST INC (MED), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.53
- Revenue Estimate
- 69.892M
Last Reported
Most Recent- Release Date
- Feb 17, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$1.65
- EPS Surprise
- -99.23%
- Revenue Surprise
- 0.75%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.65 | -0.83 | -99.23% | -1,750.00% | 75.096M | 74.538M | 0.75% | -36.90% |
| Q3 2025 | -0.21 | -0.39 | 46.69% | -160.00% | 89.409M | 84.941M | 5.26% | -36.21% |
| Q2 2025 | 0.22 | -0.22 | 199.01% | -76.09% | 105.555M | 97.061M | 8.75% | -37.38% |
| Q1 2025 | -0.11 | -0.27 | 59.66% | -116.67% | 115.728M | 111.2M | 4.07% | -33.77% |
| Q4 2024 | 0.10 | -0.16 | 161.88% | -81.82% | 119.003M | 115.39M | 3.13% | -37.70% |
| Q3 2024 | 0.35 | -0.28 | 225.10% | -83.49% | 140.163M | 135.49M | 3.45% | -40.58% |
| Q2 2024 | 0.92 | 0.39 | 133.56% | -66.79% | 168.558M | 175.79M | -4.11% | -43.09% |
| Q1 2024 | 0.66 | 0.79 | -16.22% | -82.02% | 174.739M | 170.59M | 2.43% | -49.93% |
| Q4 2023 | 0.55 | 0.97 | -43.28% | -83.18% | 191.015M | 185.99M | 2.70% | -43.35% |
| Q3 2023 | 2.12 | 1.08 | 97.09% | -35.17% | 235.869M | 234.42M | 0.62% | -39.58% |
| Q2 2023 | 2.77 | 1.45 | 90.46% | -19.01% | 296.188M | 272.95M | 8.51% | -34.66% |
| Q1 2023 | 3.67 | 2.42 | 51.53% | 2.23% | 348.983M | 322.71M | 8.14% | -16.43% |
| Q4 2022 | 3.27 | 2.24 | 45.84% | 12.37% | 337.2M | 333.4M | 1.14% | -10.75% |
| Q3 2022 | 3.27 | 1.93 | 69.51% | -8.15% | 390.4M | 352.79M | 10.66% | -5.56% |
| Q2 2022 | 3.42 | 3.27 | 4.69% | -13.64% | 453.3M | 452.33M | 0.21% | 14.99% |
| Q1 2022 | 3.59 | 3.61 | -0.44% | 3.76% | 417.6M | 407.29M | 2.53% | 22.57% |
| Q4 2021 | 2.91 | 2.68 | 8.59% | 23.31% | 377.8M | 379.55M | -0.46% | 42.62% |
| Q3 2021 | 3.56 | 3.11 | 14.44% | 22.34% | 413.4M | 407.79M | 1.38% | 52.27% |
| Q2 2021 | 3.96 | 3.35 | 18.21% | 102.04% | 394.2M | 363.11M | 8.56% | 79.18% |
| Q1 2021 | 3.46 | 2.75 | 25.60% | 79.27% | 340.7M | 281.68M | 20.95% | 90.87% |
| Q4 2020 | 2.36 | 2.40 | -1.74% | - | 264.9M | 246.94M | 7.27% | - |
| Q3 2020 | 2.91 | 2.48 | 17.29% | - | 271.5M | 243.02M | 11.72% | - |
| Q2 2020 | 1.96 | 1.85 | 5.90% | - | 220M | 193.68M | 13.59% | - |
| Q1 2020 | 1.93 | 1.34 | 43.97% | - | 178.5M | 167.37M | 6.65% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
51.53%
Max EPS beat (4)
199.01%
Min EPS beat (4)
-99.23%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
4.71%
Max Revenue beat (4)
8.75%
Min Revenue beat (4)
0.75%
Analysis
In the last 4 quarters, MED has beaten EPS estimates in 3 out of 4 releases
MED has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, MED has beaten the EPS estimates by 51.5% on average.
In the last 4 quarters, MED has beaten the revenue estimates by 4.7% on average.
Related analysis
MEDIFAST INC / MED Earnings FAQ
Can you provide information on whether MEDIFAST INC beat earnings estimates in the last quarter?
MEDIFAST INC (MED) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often MEDIFAST INC beats earnings estimates?
In the last 4 quarters, MEDIFAST INC (MED) has beaten EPS estimates in 3 out of 4 releases.